HOME >> BIOLOGY >> NEWS
UCSF set to transform itself into engine of translational research

Signaling a watershed moment in the evolution of UCSF, the National Insitutes of Health today announced that the University has received funding for a major new venture designed to accelerate the pace at which scientific discovery is translated into patient care.

The highly competitive funding mechanism, known as the Clinical and Translational Science Award, is being issued under the "NIH Roadmap," a strategic plan unveiled by NIH Director Elias A. Zerhouni, MD, in 2002 to drive the future of biomedical research.

Universities were encouraged to develop proposals to establish departments, centers or institutes, funded over five years, that would support innovative and far-reaching approaches for carrying out translational and clinical science. Seven universities, including UCSF, received funding for a full institute.

The UCSF Institute will be supported with more than $100 million over a period of five years.

The NIH funding mechanisms will support a nationwide consortium of departments, centers and institutes, beginning with 12 academic medical centers. When fully implemented in 2012, approximately 60 will be linked in the common effort.

"The development of this consortium represents the first systematic change in our approach to clinical research in 50 years," said Zerhouni. "These sites will serve as discovery engines that will improve medical care by applying new scientific advances to real world practice."

The UCSF Clinical and Translational Science Institute will extend across all four schools Dentistry, Medicine, Nursing, Pharmacy and its graduate division. It is designed to create an enterprise that promotes research and education in translational and clinical science at UCSF and its affiliated institutions, including the J. David Gladstone Institutes. The enterprise also will include Children's Hospital Oakland Research Institute, the Blood Systems Research Institute of San Francisco, the Kaiser Permanent Health System,
'"/>

Contact: Jennifer O'Brien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
3-Oct-2006


Page: 1 2 3 4 5

Related biology news :

1. New science of metagenomics will transform modern microbiology
2. Carnegie Mellon scientists use green approach to transform plastics manufacturing
3. NIH launches national consortium to transform clinical research
4. Science researchers genetically transform immune cells into tumor fighters
5. Completed genome set to transform the cow
6. UCLA researchers transform stem cells found in human fat into smooth muscle cells
7. Microbes transform safest PBDEs into more harmful compounds
8. Supercomputers to transform science
9. Gene needed for butterfly transformation also key for insects like grasshoppers
10. Amazonian terra preta can transform poor soil into fertile
11. Carnegie Mellon U. transforms DNA microarrays with standard Internet communications tool

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... ... Disappearing forests and increased emissions are the main causes of the evolving ... those living in larger cities are affected by air pollution related diseases. , That ... countries globally - decided to take action. , “I knew I had to take ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... ... 10, 2017 , ... Dr. Bob Harman, founder and CEO of VetStem ... The event entitled “Stem Cells and Their Regenerative Powers,” was held ... Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief ...
Breaking Biology Technology:
Cached News: